Atieh Nouralishahi

Atieh Nouralishahi

Auto-generated profile, based on publicly available information

Atieh Nouralishahi

Sub-Department of Operations and Analytics, Department of Management, Faculty of Environment, Science and Economy, University of Exeter, Exeter, United Kingdom

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2024 in Journal of Dental Education
Verified
Journal Article
Closed access
AYAmir Yari
Amir Yari
PFPaniz Fasih
Paniz Fasih
AGAli Goodarzi
Ali Goodarzi
ANAtieh Nouralishahi
Atieh Nouralishahi
DNDorsa Nikeghbal
Dorsa Nikeghbal

25 October 2023 in Dental Traumatology
Verified
Journal Article
Closed access
AYAmir Yari
Amir Yari
MHMahboube Hasheminasab
Mahboube Hasheminasab
PFPaniz Fasih
Paniz Fasih
ANAtieh Nouralishahi
Atieh Nouralishahi
SAS. Marjan Arianezhad
S. Marjan Arianezhad

19 May 2024 in Oral Science International
Verified
Journal Article
Closed access
AYAmir Yari
Amir Yari
PFPaniz Fasih
Paniz Fasih
ANAtieh Nouralishahi
Atieh Nouralishahi
MMMeysam Mohammadikhah
Meysam Mohammadikhah
DNDorsa Nikeghbal
Dorsa Nikeghbal

4 April 2024 in Immunopathologia Persa
Verified
Journal Article
Open access
PDF file
EMElham Mohammadzadeh
Elham Mohammadzadeh
RARazieh Bagheri Shahzadeh Aliakbari
Razieh Bagheri Shahzadeh Aliakbari
ANAtieh Nouralishahi
Atieh Nouralishahi
AKAmin Khameneh
Amin Khameneh
BGBabak Gholamine
Babak Gholamine
EZElahe Zaremoghadam
Elahe Zaremoghadam
Introduction: Colorectal cancer (CRC) ranks as the third most prevalent diagnosed tumor worldwide. While the association between constipation and certain tumors has been established, our study aims to examine the relationship between constipation and colorectal tumors. Materials and Methods: This study employed a systematic review and meta-analysis following the PRISMA reporting guidelines. Searches were conducted without time restrictions until November 4, 2023, across various databases, including PubMed, Scopus, Web of Science, Cochrane, and the Google Scholar search engine. Data analysis was performed using STATA 14, and statistical significance was indicated by P<0.05. Results: This meta-analysis included 18 studies (9 cohort studies and 9 case-control studies) with a total sample size of 1,462,496 individuals. Overall, no significant association was found between constipation and colorectal tumors (OR: 1.09, 95% CI: 0.91–1.31), colon tumor (OR: 1.09, 95% CI: 0.89–1.34), and rectal tumor (OR: 0.95, 95% CI: 0.69–1.32). Subgroup analysis, however, revealed no statistically significant association between constipation and colorectal tumors (OR: 0.93, 95% CI: 0.76–1.14), colon tumors (OR: 0.92, 95% CI: 0.75–1.13), and rectal tumor (OR: 0.92, 95% CI: 0.65–1.21) in cohort studies. In case-control studies, constipation was associated with an increased risk of colorectal tumors (OR: 1.78, 95% CI: 1.12–2.83) and colon tumors (OR: 2.32, 95% CI: 1.58–3.42), while the association between constipation and rectal tumor in case-control studies was (OR: 1.40 (95% CI: 0.62, 2.89). Conclusion: In case-control studies, constipation emerged as a risk factor for colorectal and colon tumors, raising concerns given the high prevalence of constipation globally. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (CRD42023481321) and Research Registry (UIN: reviewregistry1741) website.

17 November 2023 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
SASoleyman Alivand
Soleyman Alivand
FFFarinaz Fattahi
Farinaz Fattahi
ZZZahra Zarei
Zahra Zarei
MHMehdi Hosseinifard
Mehdi Hosseinifard
ANAtieh Nouralishahi
Atieh Nouralishahi
ADAnna Ghorbani Doshantapeh
Anna Ghorbani Doshantapeh
Introduction: Population categories based on income levels are frequently utilized to compare cancer rates across various countries. It is a valuable tool for assessing global health and helps to classify cancers and measure the incidence and mortality of different types of cancer. Objectives: This study aimed to evaluate global kidney cancer incidence and mortality rates in 2020 according to population category by income levels, using an ecological study design. Methods and Materials: This ecological study examines the correlation between the incidence and mortality of kidney cancer in 2020, reported by the GLOBOCAN project, since the population category by income levels was reported by the World Bank report. The linear regression method was conducted to assess this correlation. Results: Results demonstrated that the global incidence and mortality rate of kidney cancer in 2020 was estimated at 431288 and 179368 cases, respectively. The incidence and mortality rate of kidney cancer were higher in high-income countries, and both rates tend to be higher in more developed regions. However, there was no statistically significant correlation between the population category by income levels and kidney cancer incidence and mortality based on both crude rate (CR) and age-standardized rate (ASR) indicators (P>0.05). Conclusion: We conclude that incidence and mortality rates of kidney cancer are not associated with population category by income level.

24 June 2024 in Journal of Nephropathology
Verified
Journal Article
Open access
ADAnna Ghorbani Doshantapeh
Anna Ghorbani Doshantapeh
ANAtieh Nouralishahi
Atieh Nouralishahi
ACAnahid Cheraghalian
Anahid Cheraghalian
NANavid Asgari
Navid Asgari
RARazieh Bagheri Shahzadeh Aliakbari
Razieh Bagheri Shahzadeh Aliakbari
SKSeyede Sara Pakdaman Kolour
Seyede Sara Pakdaman Kolour
Introduction: Statins reduce the cancer risk; however, non-Hodgkin lymphoma (NHL) evidence remains controversial. Therefore, we aimed to evaluate the relationship between statin consumption and NHL risk using a systematic review and meta-analysis. Materials and Methods: In this systematic review and meta-analysis, international databases, including Scopus, PubMed, Web of Science, Cochrane, and Google Scholar search engines, were searched without a time limit up to September 21, 2023. Data analysis was performed using STATA 14 software, and the significance level was considered P<0.05. Results: The results of combining 13 studies (9 case-control studies and 4 cohort studies) with a total sample size of 1142 740 subjects showed that statin consumption could reduce NHL risk by 22% (RR: 0.78; 95% CI: 0.69, 0.88). Statin consumption in cohort studies reduced NHL risk by 14% (RR: 0.86; 95% CI: 0.77, 0.95), but in case-control studies, it reduced NHL risk by 26% (RR: 0.74; 95% CI: 0.62, 0.90). Furthermore, statin consumption reduced diffuse large B-cell lymphoma risk by 24% (RR: 0.76; 95% CI: 0.67, 0.87) and marginal zone risk by 26% (RR: 0.74; 95% CI: 0.59, 0.93). However, it did not affect reducing the risk of chronic lymphocytic leukemia/small lymphocytic lymphoma (RR: 0.94; 95% CI: 0.85, 1.05), follicular (RR: 0.96; 95% CI: 0.83, 1.10), plasma cell neoplasms (RR: 0.97; 95% CI: 0.70, 1.33), T cell lymphoma (RR: 0.81; 95% CI: 0.55, 1.19) and B cell lymphoma (RR: 0.94; 95% CI: 0.44, 2.01). Conclusion: Statin consumption significantly reduced the risk of NHL, diffuse large B-cell lymphoma, and marginal zone but did not affect other NHL types. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (CRD42023469126) and Research Registry (UIN: reviewregistry1732) website.